LD-2 disclosure · 2nd Quarter - Report
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client
- Name
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Description
- Charitable funder of diabetes research
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Issues related to NIH & ARPA-H Funding S. 2131/H.R. 4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO · CHRISTINA INGRAM
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 2547 - Special Diabetes Program for Indians Reauthorization Act of 2023 H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1855 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 1488 - Affordable Insulin Now Act S. 954 - Affordable Insulin Now Act H.R. 3561 - PATIENT Act of 2023 Issues related to insulin affordability Issues related to collection of race and ethnicity data Issues related to Medicare and Medicaid Issues related to preventative care
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO · CHRISTINA INGRAM
TargetedSENATE · HOUSE OF REPRESENTATIVES